MUMBAI The rupee rose to a two-week high on Friday, notching up a second consecutive week of gains, helped by inflows tied to a domestic share sale and by a weaker dollar after strong U.S. data raised chances of an early retreat from monetary easing.
The government was selling a 5 percent stake in state-run National Aluminium Co Ltd to raise at least 5.1 billion rupees.
The rupee also benefited as the dollar weakened globally after strong U.S. economic data raised the prospect the U.S. Federal Reserve may retreat earlier from its monetary easing programme.
Still, investors are widely looking ahead at the Reserve Bank of India's policy review on Tuesday amid expectations that the central bank will cut interest rates by 25 basis points in a bid to support economic growth.
"Corporate selling in the morning and gains in the euro have helped the rupee despite stocks turning negative," said Naveen Raghuvanshi, associate vice president at Development Credit Bank.
"If there is a rate cut on Tuesday, equities may gain and the rupee may rise to 53.70-53.75 levels."
The partially convertible rupee closed at 54.02/03 per dollar versus its previous close of 54.355/365. It rose to 53.97 in the session, the highest level since February 28.
The rupee gained 0.6 percent on the day, its biggest daily rise since January 30. For the week, it rose 0.5 percent.
Broader gains were capped after a Standard & Poor's analyst said the slowdown in India's growth was less supportive for the country's sovereign credit ratings.
S&P rated India at "BBB-minus", one notch above junk, and cut its outlook to "negative" from "stable" last year, denoting a one-in-three possibility of a ratings downgrade.
In the offshore non-deliverable forwards, the one-month contract was at 54.44, while the three-month was at 55.02.
In the currency futures market, the most-traded near-month dollar/rupee contracts on the National Stock Exchange, the MCX-SX and the United Stock Exchange all closed at around 54.19 with a total traded volume of $5.1 billion.
(Editing by Subhranshu Sahu)
FDA warns former Sun Pharma U.S. drug factory over quality concerns
MUMBAI The U.S. Food and Drug Administration has pulled up a former Sun Pharmaceutical drug factory for "knowingly" releasing 27 lots of the hypertension drug clonidine last year, despite proof that the raw materials used may have been contaminated.
Sensex posts worst weekly fall in nearly four months; Fed awaited
The BSE Sensex posted its worst week since early May on Friday, as investors stayed on the sidelines ahead a speech by U.S. Federal Reserve Chair Janet Yellen in Jackson Hole, Wyoming later in the day.
Net1 to invest up to $40 million in MobiKwik over two years
MUMBAI Payment services provider Net1 UEPS Technologies Inc will invest up to $40 million in Indian mobile wallet services provider MobiKwik over the next 24 months, the companies said in a joint statement on Friday.